EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibroblast MrgprX2/B2 signaling drives hypertrophic scar fibrosis

Heng Xu, Meiying Sheng, Yuxin Jia, Yi Luo, Liyan Wu, Luxian Zhou, Zihan Wang, Jiawei Sun, Tianyi Shen, Liqin Zhou, Ting Wang, Yan Liu und 2 weitere

Cell Reports · 2026-07 · 45 (7) · 117616

DOI: 10.1016/j.celrep.2026.117616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Heng Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Fibroblasts, Signal Transduction, Nerve Tissue Proteins. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Natural Science Foundation, National Key Research and Development Program of China Stem Cell and Translational Research, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic scarring (HTS) represents a common clinical challenge characterized by excessive fibroblast activation and tissue fibrosis. However, the upstream signals driving pathological fibroblast proliferation remain poorly understood. Here, we identify the G protein-coupled receptor MrgprX2 (human)/MrgprB2 (mouse), traditionally restricted to mast cells, as an inducible pro-fibrotic receptor in dermal fibroblasts during HTS progression. MrgprX2 is markedly upregulated in dermal fibroblasts from HTS, and pharmacological inhibition of MrgprX2 significantly reduces fibrosis in humanized skin organoid models. In mouse studies, the endogenous peptide LL37 emerged as an MrgprX2/B2 activator in fibroblasts, triggering calcium influx, transforming growth factor β1 (TGF-β1) secretion, and proliferation. Genetic ablation of MrgprB2 in fibroblasts significantly reduced fibrosis in vivo, establishing the LL37-MrgprX2/B2-TGF-β1 axis as a key mediator of fibroblast activation and fibrotic remodeling. Together, our findings position MrgprX2/B2 as a critical molecular link between tissue injury-associated signals and fibrotic pathology, offering a promising therapeutic target for fibroblast-driven fibrosis in HTS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledFibroblastsSignal TransductionNerve Tissue ProteinsCicatrix, HypertrophicReceptors, NeuropeptideAnimalsHumansFibrosisMiceTransforming Growth Factor beta1Cell ProliferationMice, Inbred C57BL

Stichwörter der Autor:innen

CP: cell biologyCP: immunologyMrgprB2MrgprX2fibroblastfibrosishypertrophic scarskin

Substanzen

Receptors, G-Protein-CoupledNerve Tissue ProteinsReceptors, NeuropeptideMrgprx2 protein, mouseMRGPRX2 protein, humanTransforming Growth Factor beta1Mrgprb2 protein, mouse

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China; Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth…
  • Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
  • Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China; Department of Burn and Plastic Surgery, Beijing Children's Ho…
  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Shanghai 201203, China.
  • Research Center, Shanghai Archgene Biotechnology Co., Ltd, Shanghai 200011, China.
  • Genekinder Medicaltech (Shanghai) Co., Ltd, Shanghai 200011, China.

Förderung

  • Shanghai Municipal Natural Science Foundation
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Chinese Academy of Sciences
  • National Major Science and Technology Projects of China
  • Shanghai Rising-Star Program
  • State Key Laboratory of Medicinal Chemical Biology
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Xu, H., Sheng, M., Jia, Y., Luo, Y., Wu, L., Zhou, L., Wang, Z., Sun, J., Shen, T., Zhou, L., Wang, T., Liu, Y., Feng, J., & Zhang, Y. (2026). Fibroblast MrgprX2/B2 signaling drives hypertrophic scar fibrosis. Cell Reports, 45(7), 117616. https://doi.org/10.1016/j.celrep.2026.117616

Vancouver

Xu H, Sheng M, Jia Y, Luo Y, Wu L, Zhou L, et al. Fibroblast MrgprX2/B2 signaling drives hypertrophic scar fibrosis. Cell Reports. 2026;45(7):117616. doi:10.1016/j.celrep.2026.117616

BibTeX
@article{Xu2026,
  author = {Xu, Heng and Sheng, Meiying and Jia, Yuxin and Luo, Yi and Wu, Liyan and Zhou, Luxian and Wang, Zihan and Sun, Jiawei and Shen, Tianyi and Zhou, Liqin and Wang, Ting and Liu, Yan and Feng, Jing and Zhang, Yixin},
  title = {Fibroblast MrgprX2/B2 signaling drives hypertrophic scar fibrosis},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {117616},
  doi = {10.1016/j.celrep.2026.117616}
}
Kostenlos starten →